The knockdown of FLI1 via the CRISPR/Cas9 approach more efficiently prevented the cellular proliferation and migration of SCLC cells compared to shRNA-dependent knockdown that targeted the 3’ region of FLI1 mRNA.89 The gene discussed is FLI1; the disease is small cell lung carcinoma.